Status:

SUSPENDED

The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma

Lead Sponsor:

Medical University of Vienna

Conditions:

Multiple Myeloma

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Multiple myeloma is the second most common haematological cancer with a cancer incidence of around 500 new cases in Austria per year . Novel treatment methods have significantly increased the cancer-s...

Detailed Description

The aim of this study is to investigate the feasibility and effectiveness of individualized training support for multiple myeloma patient populations divided into high and low risk according to their ...

Eligibility Criteria

Inclusion

  • Multiple Myeloma after primary Treatment
  • Sufficient knowledge of the German language to being able to follow the study procedures
  • Cardiologic-internal clearance for exercise

Exclusion

  • Fulfillment of absolute exclusion criteria of the cardiovascular system or on the musculoskeletal system with regard to physical trainability
  • Insufficient language knowledge
  • Cognitively unable to follow the course of the study
  • Severe mental illness

Key Trial Info

Start Date :

March 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT04300335

Start Date

March 1 2026

End Date

December 1 2026

Last Update

October 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University of Vienna

Vienna, Austria, 1090